Conference Description:

WELCOME REMARK

On behalf of the organizing committee, we warmly welcome you to join in the The 2nd World Brain Disorders and Neuroscience Summit (BDNS 2023), which will be held during Nov. 9-11 (Tue-Thu) in Singapore with hybrid format.

BDNS 2023 includes plenary forum, 16 breakout sessions, as well as poster exhibition in the three-day scientific program. The main topics include Brain Stimulation and Neuroimaging, Biology of Aging and Gerontology, Breakthrough in Psychiatry and Psychology, Cognitive Neuroscience and Mental Health, Latest Research in Brain Structure and Function, Neuropharmacology and Anti-neurodegenerative Drug Discovery, Neuroinformatics and Computational Neuroscience, etc.

BDNS 2023 brings together the best scientists from universities, research institutes and the hospitals worldwide to share exciting results and to build new collaborations.

We hope you can join your peers in a highly interesting and engaging hybrid event with online and offline. Your presence and deliberation will make this congress remarkably successful.

Website: https://bdns2023.lmsii.org/; https://bdns2023.vowcongress.cn/

Contact us: Ms. Ida Hoi Email: [email protected]

Topics?
Alzheimer's Diseases and Neurodegenerative Disease;
Breakthrough in Psychiatry, Psychology and Mental Health;
Neurosciences and Neurobiology;
Clinical and Translational Neurology;
Stroke and CNS Injury & Repair;
Latest Research in Brain and Blood Brain Barrier;
Parkinson's Diseases;
Pain Research and Management

Renowned Speakers Of BDNS 2023

Dr. Gert Fricker, Heidelberg University, Germany;
Dr. Rocco J. Gennaro, University of Southern Indiana, USA;
Dr. Jean Golding, University of Bristol, UK;
Dr. Hamid Borghei-Razavi, Cleveland Clinic Florida, USA;
Dr. Craig Granowitz, Lexicon Pharmaceuticals Inc., USA;
Dr. Nigel Marsh, James Cook University, Singapore;
Dr. Shishuka Malhotra, NeuroBehavioral Clinical Research, USA;
Dr. Robert Logan, Eastern Nazarene College, USA;
Dr. Zineb Ammous, The Community Health Clinic, USA;
Dr. Christine N. Sang, Harvard Medical School, USA;
Dr. Pavel Novak, Storz Medical AG, Switzerland;
Dr. Charles S. Wilcox, Praxis Research Consulting, USA;